BIOTECHNOLOGY advocacy group AusBiotech has announced the retirement of ceo Glenn Cross, who is stepping down after 13 years with the organisation.
Following his departure in early Jul he will be replaced by Lorraine Chiroiu, who is currently the group's deputy ceo.
During his time with AusBiotech Cross has made "numerous and significant" contributions according to chairman Julie Phillips, including building AusBiotech's Global Investment Program and establishing the annual conference.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 May 18
